Feature|Articles|April 17, 2024
- Pharmaceutical Executive: April 2024
- Volume 44
- Issue 4
Pharmaceutical Executive: April 2024 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive April 2024 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 2 years ago
Power in Partneringover 2 years ago
The IRA Impact: Navigating Its Evolving Complexitiesover 2 years ago
Fighting for Innovationover 2 years ago
Say Hello to Flexible: Reimagining the Patient Journeyover 2 years ago
Aspiring for the C-Suite? Consider Being a Chief of Staffover 2 years ago
Latent Benefit of Access Restrictions for Rare Conditionsover 2 years ago
The Pharmaceutical Playbook for Asia’s Private Marketover 2 years ago
Operating Models for Successful DOL EngagementAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
2
Bristol Myers Squibb Expands Collaboration with Nvidia to Build AI Factory
3
Staying Ahead of Viral Evolution: Q&A with Robert Allen, Ph.D
4
Pharmaceutical Executive Daily: Bristol Myers Squibb Expands Partnership with Nvidia
5